MSB Holders Only, page-6

And again might be self serving referring to this as a quality post however factual.!

https://hotcopper.com.au/posts/51404095/single

On Jan11 Rexlemestrocel RCT (that's random control trial) Result announced great headline,

REXLEMESTROCEL Reduces Heart Attacks/Stokes/CV Death in CHF

And SI states in webcast CHF will be partnered targeting big pharma!

On 12 Jan CHF Phase3 Results Presented at Investor (there's that pesty word again) Conference.

On Feb 11( a month for large investors to get their head around CHF Results) Second RCT drops.

Mesoblast Chronic Lower Back Results.

In that the hidden headline of 100% of dosed patients experience pain reduction and reduced opiod use.
I'm sure no one considering CHF results had no interest in this second RCT confirming Tech Works! Novartis probably glanced the announcement and moved on!!!!

Six days later there is a article published in a Pediatrics Journal something about two kids who immediately saw improved biomarkers after dosing with Remestemcel-L and who's hearts returned to normal and returned home in timely manner.

Now what was it that Novartis Stated in the ARDS Deal announcement? Something about how pleased they were to be investing in life saving medicines that make a real difference. (Paraphrased)

Then 9 days later there is a trading halt stating Stating Equity Placement to Targeted Investor.

Well I'll be buggered!!! !

How did that happen!!!!